Is Albany Molecular Research, Inc. (AMRI) A Good Stock To Buy?
Looking for high-potential stocks? Just follow the big players within the hedge fund industry.
Albany Molecular Research Inc (AMRI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ancora Advisors Frederick Disanto | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.46 | 1,518 | Director | 7,408 | 2016-12-02 | Filing | |
| $12.82 | 12,500 | Officer | 108,685 | 2016-05-13 | Filing | |
| $12.86 | 12,500 | Officer, Director | 524,143 | 2016-05-16 | Filing | |
| $19.98 | 10,000 | Officer, Director | 447,214 | 2015-06-04 | Filing | |
| $17.72 | 10,000 | Officer | 70,673 | 2015-03-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.71 | 9,000 | Officer | 34,913 | 2016-11-30 | Filing | |
| $17.00 | 6,000 | Officer | 51,337 | 2016-11-16 | Filing | |
| $16.79 | 785 | Officer | 34,913 | 2016-11-10 | Filing | |
| $15.29 | 1,401 | Officer | 36,163 | 2016-08-09 | Filing | |
| $14.41 | 5,000 | Director | 47,955 | 2016-05-31 | Filing |
Institutional Investors' Holdings
News See All
Hedge Funds Are Buying Albany Molecular Research, Inc. (AMRI)
Albany Molecular Research, Inc. (NASDAQ:AMRI) was in 12 hedge funds' portfolio at the end of the first quarter of 2013.
Hedge Funds Are Buying Albany Molecular Research, Inc. (AMRI): Osiris Therapeutics, Inc. (OSIR), 3SBio Inc. (ADR) (SSRX)
Is Albany Molecular Research, Inc. (NASDAQ:AMRI) the right investment to pursue these days? Investors who are in the know are in an optimistic mood.
Zillow Inc (Z), Trulia Inc (TRLA), Best Buy Co., Inc. (BBY) & More: Four Stocks That Have Almost Doubled in 2013
The market's off to a hot start.
3 Healthcare Stocks Trading at Attractive Multiples: The Cooper Companies, Inc. (COO), Albany Molecular Research, Inc. (AMRI), Cambrex Corporation (CBM)
Healthcare stocks, in general, have had a nice rally recently, with many shares outperforming the S&P 500 Index. Despite the rally, some stocks in this sector are still attractively priced. Three ...
3 Top Earning Performers You Might Want to Buy: Masco Corporation (MAS)
Earnings and earning-related news is the number one catalyst for stock movement.